Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Non-interventional, Multicenter, Prospective Study to Explore the Association of MS-related Disability Worsening and Loss of Thalamus Volume.

NCT07753928 is registered in ClinicalTrials.gov with Jung Diagnostics GmbH as lead sponsor.

NCT NCT07753928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07753928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Non-interventional, Multicenter, Prospective Study to Explore the Association of MS-related Disability Worsening and Loss of Thalamus Volume.
Lead sponsor
Jung Diagnostics GmbH
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 1, 2022
Completion date
June 30, 2033
Enrollment
2,400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis